Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer

Not Applicable

• Conditions: Liver Cancer
• Interventions: Device: hsp90

• Registration Number: NCT02324127
• Lead Sponsor: Protgen Ltd

Brief Summary

Detect plasma Hsp90α concentration of liver cancer patients, healthy volunteers, benign liver diseases.

Detailed Description

Detect plasma Hsp90α concentration of liver cancer patients, healthy volunteers, benign liver diseases, validate accuracy, specificity and sensitivity of Hsp90α kit.

Study Timeline

• Study Start: 2012-10
• Status Verified: 2014-12
• Primary Completion: 2014-12
• Study Completion: 2014-12
• Study First Submitted: 2014-12-14
• Study First Submitted QC: 2014-12-23
• Last Update Submitted: 2014-12-23
• Study First Posted: 2014-12-24
• Last Update Posted: 2014-12-24

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1100

Inclusion Criteria

• Liver cancer patients
• Healthy volunteers,
• Benign liver diseases patients

Exclusion Criteria

• Patients who Previously accepted radiotherapy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
liver cancer	hsp90	Detect plasma Hsp90α concentration of liver cancer patients

Primary Outcome Measures

Name	Time	Method
Hsp90α Concentration of plasma	4 months	Detect Hsp90α Concentration(ng/ml) of plasma and calculate the accuracy, specificity and sensitivity of Hsp90α kit

Trial Locations

Locations (1)

Zhejiang Medical University Cancer Institute and Hospital; 🇨🇳 Hangzhou, Zhejiang, China